Tyler J. Curiel

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

Tyler J. Curiel, George Coukos, Linhua Zou et al. · Nature Medicine · 2004 · 5K citations

Cancer Immunosurveillance, Specific Recruitment, T-regulatory Cell +9

Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity

Tyler J. Curiel, Shuang Wei, Haidong Dong et al. · Nature Medicine · 2003 · 1.3K citations

Cancer Immunosurveillance, Immunology, Tumor Immunity +5

Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes

Terri H. Finkel, Gareth Tudor‐Williams, Nirmal K. Banda et al. · Nature Medicine · 1995 · 945 citations

Bystander Cells, Human Retrovirus, Apoptosis +12

Safety and Efficacy of Durvalumab (MEDI4736), an Anti–Programmed Cell Death Ligand-1 Immune Checkpoint Inhibitor, in Patients With Advanced Urothelial Bladder Cancer

Christophe Massard, Michael S. Gordon, Sunil Sharma et al. · Journal of Clinical Oncology · 2016 · 839 citations · Full text

B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma

Ilona Kryczek, Linhua Zou, Paulo C. Rodrı́guez et al. · The Journal of Experimental Medicine · 2006 · 733 citations · Full text

B7-h4 Expression, Tumor-associated Macrophages, Normal Macrophages +22